Back to Search

NPCE

Neuropace, Inc. Common Stock
Data: 2026-07-31
$12.89
Price
-6.25%
Change
$19.60
52W High
$7.56
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Quick Stats
Jul 31, 2026

49.7

AI Score

HOLD

1.7

Volume Ratio

Aug 11, 2026

Next Earnings

19

+ve Days (30d)

11

-ve Days (30d)

NPCE Stock Summary

Last updated Jul 31, 2026

NPCE is currently trading at $12.89, positioned below its 200-day moving average of $15.1, suggesting bearish momentum. The stock has a 52-week range of $7.5625 to $19.6.

Technical Analysis: The 50-day moving average stands at $15.93, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.56, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.196, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NPCE at 49.7/100 with a HOLD recommendation.

NPCE (Neuropace, Inc. Common Stock) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 29.56
CMF (20) -0.196
ROC (10) -19.838
ADX (14) 17.899
Indicator Value
MACD (12,26,9) -0.67
AROONOSC (14) -92.857
WILLAMS %R (14) -95.636
MFI (14) 23.484
NPCE Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NPCE Price vs Max Options Open Interest
NPCE Max Change In Options Open Interest

NPCE Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NPCE Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NPCE Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

NPCE Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Neuropace, Inc. Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

NPCE Moving Averages Analysis

NPCE (Neuropace, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 14.62
20 15.69
30 15.81
50 15.93
100 15.61
200 15.1

NPCE Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 468.8 million
Earnings/Share ($) -0.65
Net Profit Margin (%) -0.2167
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.5439
EPS Estimate Next Year ($) -0.2938
WallStreet Target Price ($) 20.22
Most Recent Quarter